Patents by Inventor Boris Rubinsky

Boris Rubinsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140309579
    Abstract: Restenosis or neointimal formation may occur following angioplasty or other trauma to an artery such as by-pass surgery. This presents a major clinical problem which narrows the artery. The invention provides a balloon catheter with a particular electrode configuration. Also provided is a method whereby vascular cells in the area of the artery subjected to the trauma are subjected to irreversible electroporation which is a non-thermal, non-pharmaceutical method of applying electrical pulses to the cells so that substantially all of the cells in the area are ablated while leaving the structure of the vessel in place and substantially unharmed due to the non-thermal nature of the procedure.
    Type: Application
    Filed: June 24, 2014
    Publication date: October 16, 2014
    Applicants: ANGIODYNAMICS, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: BORIS RUBINSKY, ELAD MAOR, ANTONI IVORRA, JAMES J. MITCHELL, WILLIAM C. HAMILTON
  • Patent number: 8835166
    Abstract: Extracellular matrix material is disclosed which is created by subjecting a target area to non-thermal irreversible electroporation (NTIRE) with a pulsed electrical field to kill cells in the absence of thermal damage. The dead cellular material may be removed and the remaining non-cellular matrix material may be implanted into a repair site to be treated medically or cosmetically.
    Type: Grant
    Filed: September 2, 2010
    Date of Patent: September 16, 2014
    Assignee: The Regents of the University of California
    Inventors: Mary Phillips, Elad Maor, Boris Rubinsky, Jacob Lavee
  • Publication number: 20140176158
    Abstract: A method and apparatus of determining the condition of a bulk tissue sample, by: positioning a bulk tissue sample between a pair of induction coils (or antennae); passing a spectrum of alternating current (or voltage) through a first of the induction coils (or antennae); measuring spectrum of alternating current (or voltage) produced in the second of the induction coils (or antennae); and comparing the phase shift between the spectrum of alternating currents (or voltages) in the first and second induction coils (or antennae), thereby determining the condition of the bulk tissue sample.
    Type: Application
    Filed: December 17, 2013
    Publication date: June 26, 2014
    Inventors: Boris Rubinsky, Cesar A. Gonzalez
  • Publication number: 20140163551
    Abstract: Restenosis or neointimal formation may occur following angioplasty or other trauma to an artery such as by-pass surgery. This presents a major clinical problem which narrows the artery. The invention provides a device and a method whereby vascular cells in the area of the artery subjected to the trauma are subjected to irreversible electroporation which is a non-thermal, non-pharmaceutical method of applying electrical pulses to the cells so that substantially all of the cells in the area are ablated while leaving the structure of the vessel in place and substantially unharmed due to the non-thermal nature of the procedure.
    Type: Application
    Filed: June 26, 2013
    Publication date: June 12, 2014
    Inventors: ELAD MAOR, Antoni IVORRA, BORIS RUBINSKY
  • Publication number: 20140088578
    Abstract: Systems and methods are disclosed for treating a target volume of biological matter, by cooling a volume of tissue to a temperature below freezing, and directing an electric field through the cooled volume of tissue or tissue adjacent to the cooled volume of tissue to generate at least a temporary physiological affect on one or more of the cooled volume of tissue and adjacent volume of tissue. The generated physiological affect may include shielding a region of tissue from treatment, focusing treatment on a particular region of tissue, and sterilization of tissue.
    Type: Application
    Filed: September 24, 2013
    Publication date: March 27, 2014
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Boris Rubinsky, Charlotte Daniels, Yair Granot, Liel Rubinsky
  • Patent number: 8633033
    Abstract: A method and apparatus of determining the condition of a bulk tissue sample, by: positioning a bulk tissue sample between a pair of induction coils (or antennae); passing a spectrum of alternating current (or voltage) through a first of the induction coils (or antennae); measuring spectrum of alternating current (or voltage) produced in the second of the induction coils (or antennae); and comparing the phase shift between the spectrum of alternating currents (or voltages) in the first and second induction coils (or antennae), thereby determining the condition of the bulk tissue sample.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: January 21, 2014
    Assignee: The Regents of the University of California
    Inventors: Boris Rubinsky, Cesar A. Gonzalez
  • Publication number: 20130345779
    Abstract: The shape and relative positions of two or more electrodes connected to a shaped metal surface are adjusted. By adjusting the shape and position of the electrodes, as well as the shape of the metal surface, the shape of the electrical field generated from the metal surface is precisely defined. The metal surface is brought into contact with cells and the defined electrical field provides reversible or irreversible electroporation to cells in a precisely defined area. The metal surface may be comprised of copper, silver, gold or other conductive material and combinations thereof and the voltage, wattage and duration of electricity applied to the electrodes can be varied to obtain a desired result.
    Type: Application
    Filed: December 20, 2012
    Publication date: December 26, 2013
    Inventors: Elad MAOR, Antoni IVORRA, Boris RUBINSKY, Francois FERNARD, Liel RUBINSKY, Alex GOLBERG
  • Patent number: 8603087
    Abstract: A system is provided for reducing restenosis. A catheter apparatus is provided with at least first and second mono-polar electrodes positioned at an inflatable balloon. The balloon is sized to be positioned and expanded at a restenosis site. A voltage pulse generator is coupled to the first and second mono-polar electrodes. The voltage pulse generator is configured to apply an electric field, in a controlled manner, to the restenosis site in an amount sufficient to produce electroporation of the restenosis site, and below an amount that causes thermal damage to the restenosis site.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: December 10, 2013
    Assignee: AngioDynamics, Inc.
    Inventors: Boris Rubinsky, Gary Onik, Paul Mikus
  • Publication number: 20130196441
    Abstract: Provided herein are the concept that “singularity-based configuration” electrodes design and method can produce in an ionic substance local high electric fields with low potential differences between electrodes. The singularity-based configuration described here includes: an anode electrode; a cathode electrode; and an insulator disposed between the anode electrode and the cathode electrode. The singularity-based electrode design concept refers to electrodes in which the anode and cathode are adjacent to each other, placed essentially co-planar and are separated by an insulator. The essentially co-planar anode/insulator/cathode configuration bound one surface of the volume of interest and produce desired electric fields locally, i.e., in the vicinity of the interface between the anode and cathode. In an ideal configuration, the interface dimension between the anode and the cathode tends to zero and becomes a point of singularity.
    Type: Application
    Filed: May 31, 2011
    Publication date: August 1, 2013
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Boris Rubinsky, Gregory D. Troszak
  • Patent number: 8361391
    Abstract: A method and apparatus of determining the condition of a bulk tissue sample, by: positioning a bulk tissue sample between a pair of induction coils (or antennae); passing a spectrum of alternating current (or voltage) through a first of the induction coils (or antennae); measuring spectrum of alternating current (or voltage) produced in the second of the induction coils (or antennae); and comparing the phase shift between the spectrum of alternating currents (or voltages) in the first and second induction coils (or antennae), thereby determining the condition of the bulk tissue sample.
    Type: Grant
    Filed: December 16, 2011
    Date of Patent: January 29, 2013
    Assignee: The Regents of the University of California
    Inventors: Boris Rubinsky, Cesar A. Gonzalez
  • Patent number: 8348921
    Abstract: Gel compositions with adjusted conductivity are disclosed which compositions are used for directing reversible electroporation and irreversible electroporation of cells and tissue. The gel compositions are also used in a similar manner in order to carry out thermotherapy on cells and tissues.
    Type: Grant
    Filed: March 22, 2012
    Date of Patent: January 8, 2013
    Assignee: The Regents of the University of California
    Inventors: Antoni Ivorra, Boris Rubinsky
  • Publication number: 20120277741
    Abstract: A new method for the ablation of undesirable tissue such as cells of a cancerous or non-cancerous tumor is disclosed. It involves the placement of electrodes into or near the vicinity of the undesirable tissue through the application of electrical pulses causing irreversible electroporation of the cells throughout the entire area of the undesirable tissue. The electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body immune system. The amount of tissue ablation achievable through the use of irreversible electroporation without inducing thermal damage is considerable.
    Type: Application
    Filed: July 11, 2012
    Publication date: November 1, 2012
    Inventors: RAFAEL DAVALOS, Boris Rubinsky
  • Patent number: 8298222
    Abstract: A method is disclosed for disrupting capillary blood flow and trapping materials such as chemotherapeutic agents in undesirable tissue, including cells of a cancerous or non-cancerous tumor. The method involves the placement of electrodes into or near the vicinity of capillary vessels supplying blood to capillaries in the undesirable tissue, and application of electrical pulses causing capillary blood flow disruption. In some cases, the electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body's immune system. The process may further comprise monitoring blood flow and/or infusion of a material such as a chemotherapeutic agent or marker into the blood.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: October 30, 2012
    Assignee: The Regents of the University of California
    Inventors: Boris Rubinsky, Jon Edd, Liana Horowitz
  • Patent number: 8282631
    Abstract: A new method for the ablation of undesirable tissue such as cells of a cancerous or non-cancerous tumor is disclosed. It involves the placement of electrodes into or near the vicinity of the undesirable tissue through the application of electrical pulses causing irreversible electroporation of the cells throughout the entire area of the undesirable tissue. The electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body immune system. The amount of tissue ablation achievable through the use of irreversible electroporation without inducing thermal damage is considerable.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: October 9, 2012
    Assignee: The Regents of the University of California
    Inventors: Rafael Davalos, Boris Rubinsky
  • Publication number: 20120226218
    Abstract: Extracellular matrix material is disclosed which is created by subjecting a target area to non-thermal irreversible electroporation (NTIRE) with a pulsed electrical field to kill cells in the absence of thermal damage. The dead cellular material may be removed and the remaining non-cellular matrix material may be implanted into a repair site to be treated medically or cosmetically.
    Type: Application
    Filed: September 2, 2010
    Publication date: September 6, 2012
    Inventors: Mary Phillips, Elad Maor, Boris Rubinsky, Jacob Lavee
  • Publication number: 20120179091
    Abstract: Gel compositions with adjusted conductivity are disclosed which compositions are used for directing reversible electroporation and irreversible electroporation of cells and tissue. The gel compositions are also used in a similar manner in order to carry out thermotherapy on cells and tissues.
    Type: Application
    Filed: March 22, 2012
    Publication date: July 12, 2012
    Inventors: ANTONI IVORRA, Boris Rubinsky
  • Publication number: 20120146621
    Abstract: A method and apparatus of determining the condition of a bulk tissue sample, by: positioning a bulk tissue sample between a pair of induction coils (or antennae); passing a spectrum of alternating current (or voltage) through a first of the induction coils (or antennae); measuring spectrum of alternating current (or voltage) produced in the second of the induction coils (or antennae); and comparing the phase shift between the spectrum of alternating currents (or voltages) in the first and second induction coils (or antennae), thereby determining the condition of the bulk tissue sample.
    Type: Application
    Filed: December 16, 2011
    Publication date: June 14, 2012
    Inventors: Boris Rubinsky, Cesar A. Gonzalez
  • Patent number: 8162918
    Abstract: Gel compositions with adjusted conductivity are disclosed which compositions are used for directing reversible electroporation and irreversible electroporation of cells and tissue. The gel compositions are also used in a similar manner in order to carry out thermotherapy on cells and tissues.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: April 24, 2012
    Assignee: The Regents of the University of California
    Inventors: Antoni Ivorra, Boris Rubinsky
  • Publication number: 20120071872
    Abstract: A system for treating a tissue site. At least first and second mono-polar electrodes are configured to be introduced at or near a tissue site of the patient. A voltage pulse generator is coupled to the first and second mono-polar electrodes. The voltage pulse generator is configured to apply sufficient electrical pulses between the first and second mono-polar electrodes to induce electroporation of cells in the tissue site, to create necrosis of cells of the tissue site, but insufficient to create a thermal damaging effect to a majority of the tissue site.
    Type: Application
    Filed: November 28, 2011
    Publication date: March 22, 2012
    Inventors: Boris Rubinsky, Gary Onik, Paul Mikus
  • Publication number: 20120071874
    Abstract: A new method for the ablation of undesirable tissue such as cells of a cancerous or non-cancerous tumor is disclosed. It involves the placement of electrodes into or near the vicinity of the undesirable tissue through the application of electrical pulses causing irreversible electroporation of the cells throughout the entire area of the undesirable tissue. The electric pulses irreversibly permeate the cell membranes, thereby invoking cell death. The irreversibly permeabilized cells are left in situ and are removed by the body immune system. The amount of tissue ablation achievable through the use of irreversible electroporation without inducing thermal damage is considerable.
    Type: Application
    Filed: September 20, 2011
    Publication date: March 22, 2012
    Inventors: Rafael Davalos, Boris Rubinsky